BD Recalls Intraosseous Needle Sets Due to Obturator Removal Issues
Becton Dickinson is recalling specific intraosseous needle sets due to difficulties in removing the obturator after placement.
Asset / Drug
Drug and asset intelligence for BD with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.